Search results
Is AbbVie Inc. (NYSE:ABBV) the Most Undervalued Dividend Aristocrat Stock According to Analysts?
Insider Monkey via Yahoo Finance· 15 hours agoWe recently compiled the list of 25 Best Dividend Aristocrats Stocks According to Analysts. Since ...
AbbVie (ABBV) Starts Late-Stage Study on Multiple Myeloma Drug
Zacks via Yahoo Finance· 18 hours agoThe late-stage study will evaluate AbbVie's (ABBV) experimental antibody to treat patients with...
2 High-Yield Dividend Stocks to Buy Right Now | The Motley Fool
The Motley Fool· 2 days agoDividend stocks are sensitive to interest rates. When rates fall, studies show that money managers...
AbbVie (ABBV) Stock Sinks As Market Gains: What You Should Know
Zacks via Yahoo Finance· 3 days agoInvestors should also take note of any recent adjustments to analyst estimates for AbbVie. Recent...
AbbVie (ABBV) Soars 3.2%: Is Further Upside Left in the Stock?
Zacks via Yahoo Finance· 4 days agoAbbVie (ABBV) saw its shares surge in the last session with trading volume being higher than...
AbbVie Inc. (NYSE:ABBV) Receives $176.14 Average PT from Brokerages
ETF DAILY NEWS· 3 days agoBMO Capital Markets decreased their target price on AbbVie from $195.00 to $180.00 and set an “outperform” rating on the stock in a report ...
AbbVie (ABBV) Skyrizi Gets CHMP Nod for Ulcerative Colitis in EU
Zacks via Yahoo Finance· 4 days agoAbbVie (ABBV) announces that the EMA's CHMP issued a positive opinion on its regulatory filing...
3 No-Brainer Stocks to Buy in June | The Motley Fool
The Motley Fool· 5 days agoYou're probably familiar with the old adage, "April showers bring May flowers." Here's why they picked AbbVie (ABBV 3.15%), AstraZeneca (AZN 1.63%), and...
AbbVie (ABBV) Could Be a Great Choice
Zacks via Yahoo Finance· 4 days agoDividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does AbbVie (ABBV) have what it takes?...
Why Investors Are Eyeing AbbVie Inc (ABBV): The Key Drivers of M
Guru Focus· 4 days agoAbbVie Inc (ABBV, Financial) has recently captured the attention of investors and financial analysts alike, thanks to its solid financial performance and promising growth ...